GlassScriptPhysician profile
Aryian Cooke
NPI 1124225222
$3,863.43
in general payments reported to CMS, 2019-2025
26 companies · $474 in 2025
The $474 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,563 · 2020: $34.63 · 2021: $107 · 2022: $391 · 2023: $877 · 2024: $417 · 2025: $474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,754 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,754.25 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,330.10 | 2019-2022 | |
| Hologic Sales and Service, LLC | $431.25 | 2019-2024 | Acessa Provu System, Coolseal Generator, Aptima |
| Sumitomo Pharma America, INC. | $392.17 | 2023-2025 | Myfembree |
| Caldera Medical, INC | $373.89 | 2022-2023 | Desara |
| Mayne Pharma Commercial LLC | $168.37 | 2025 | |
| Astellas Pharma US INC | $164.59 | 2023-2025 | Veozah |
| Abbvie INC. | $132.81 | 2021-2025 | Liletta |
| Baxter Healthcare | $125.20 | 2023 | Floseal, Tisseel |
| Millicent US INC | $110.33 | 2019-2025 | Femring, Intrarosa, Femlyv |
| Organon LLC | $84.62 | 2023-2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $80.30 | 2020-2025 | |
| Myovant Sciences INC. | $67.81 | 2021-2022 | |
| Pfizer INC. | $65.18 | 2023-2024 | |
| Allergan, INC. | $54.49 | 2019 | |
| Coopersurgical, INC. | $48.58 | 2024 | Supercut Hysterectomy Scissors, Wallach Cryosurgical Equipment |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $39.96 | 2019-2022 | |
| Meditrina | $36.08 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $29.97 | 2019-2020 | |
| Duchesnay USA Incorporated | $24.75 | 2019 | |
| Lupin INC. | $17.37 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.98 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.69 | 2019 | |
| Therapeuticsmd, INC. | $14.80 | 2019 | |
| Mission Pharmacal Company | $13.72 | 2019 | |
| Channel Medsystems, INC. | $13.52 | 2024 | |
| Avion Pharmaceuticals | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aryian Cooke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.